Filter by: Subject

Filter by: Subject

Results Per Page:

South Africa (SA) (30)
Human immunodeficiency virus (HIV) (13)
Influenza (9)
Severe acute respiratory illness (SARI) (6)
Children (5)
Mortality (4)
Respiratory syncytial virus (RSV) (4)
Influenza-like illness (ILI) (3)
Lower respiratory tract infection (LRTI) (3)
Pneumonia (3)
Attributable fraction (2)
Coronavirus disease 2019 (COVID-19) (2)
COVID-19 pandemic (2)
Deaths (2)
Disease association (2)
Epidemiology (2)
Hospitalization (2)
Polymerase chain reaction (PCR) (2)
Rhinovirus (RV) (2)
Risk factors (2)
Severe respiratory illness (2)
Severe respiratory illness (SRI) (2)
Tuberculosis (TB) (2)
Acquired immune deficiency syndrome (AIDS) (1)
Africa (1)
Animal welfare (1)
Biosecurity (1)
Children living with HIV (CLWH) (1)
Co-infection (1)
Coinfection (1)
Conjugate vaccine (1)
Controls (1)
Crimean-Congo haemorrhagic fever (CCHF) (1)
Disease surveillance (1)
Emerging disease (1)
Endemic (1)
Enterovirus (1)
Epidemiology of influenza (1)
EV-D68 (1)
Farmers (1)
Flu-like illness (1)
Genetic diversity (1)
Genetics (1)
Genotype (1)
Healthcare utilisation (1)
HIV exposure (1)
HIV infection (1)
HIV-positive persons (1)
Hospital admissions (1)
Household (1)
Household survey (1)
Human enterovirus (HEV) (1)
Human exposure (1)
Human respiratory syncytial virus (HRSV) (1)
Illness (1)
In-hospital mortality (1)
Incidence (1)
Infection (1)
Infections (1)
Infectious diseases (1)
Influenza like illness (1)
Influenza types and subtypes (1)
Influenza vaccine effectiveness (VE) (1)
Influenza-associated hospitalization (1)
Influenza-like illness (ILI) (1)
Inpatients (1)
Invasive pneumococcal disease (IPD) (1)
Lockdown (1)
lytA (1)
Molecular serotyping (1)
National influenza vaccination policy (1)
Neuraminidase inhibitor (NAI) (1)
Oseltamivir susceptibility (1)
Outbreak (1)
Patients (1)
Pneumococcal conjugate vaccines (PCVs) (1)
Pneumococcal conjugate vaccine (1)
Pneumococcal conjugate vaccine (PCV) (1)
Pneumococcal disease (1)
Pneumococcus (1)